Patent Yard Sign in
Canadian application, no grantCanada

Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one

CA 2474811 A1 · Owner: Foguet, Rafael · Inventors: Petschen, Ines; Gordo, Esther; Ramentol, Jorge

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The process consists in condensing (2-methyl-6,7,8,9-tetrahydro-4H-pyrido-1,2a pyrimidin-3-yl)-acetaldehyde with 6-fluoro-3-piperidinyl)-1,2-benzisoxazole to yield the intermediate enamine, 3-2-4-(6-fluoro~benzodisoxazol-3-yl)piperidin-1-ylvinyl}-2-methyl~-6,7,8,9-tetrahydro-pyrido 1,2,-a pyrimidin-4one followed by reduction of such an enamine.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 3, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 3, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 3, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 3, 2003
GrantedNo grant recorded
Term endedMarch 3, 2023
Patent numberCA 2474811 A1
Classification (IPC)C07D471/04

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedMarch 3, 2003Term endedMarch 3, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.